|
|
Clinically Integrated Network Newsletter
June 17, 2020
|
|
Next Town Hall: July 15th
Mark your calendars! We continue our COVID-19 Town Hall Series on Wednesday, July 15th, 6-7:30pm. Check your email next week for an invitation and registration details.
|
|
Proactive Patient Education is Critical
Declining patient volumes will likely remain a challenge in the upcoming months; healthcare consumer surveys
have revealed patients fear seeking care isn’t safe, even as pandemic restrictions are lifted. However, the data also shows that physicians are highly trusted sources of safety information.
Now is the time to nurture your relationships with your patients to put them at ease so they can get the care they need.
|
|
Coming soon! Online Community for MSHP Providers
We are eager to launch our MSHP Provider Online Community, a place for you to network, collaborate, and converse with your colleagues in the clinically integrated network. Hosted on Microsoft Teams, this community offers the ability to join group discussions, send private messages, video calls, share links and files, and more from any internet-connected device.
Stay tuned for more information in the coming weeks.
|
|
June is PTSD Awareness Month
Nearly everyone will experience a range of reactions after trauma, yet most people recover from initial symptoms naturally. Those who continue to experience problems may be diagnosed with PTSD.
Anyone can develop PTSD at any age
. This includes veterans, children, and people who have been through an accident, disaster, or other serious events.
Learn more
.
|
|
Resumption of Cancer Clinical Trials at the Tisch Cancer Institute
During the height of the pandemic, many of Mount Sinai’s cancer clinical trials were closed to patient accrual in order to focus on COVID-19 treatment protocols and to protect cancer patients from risk exposure. We are now resuming enrollment on cancer clinical trials that are the most critical for our patients, and have been approved for re-opening by the IRB. Additional trials will continue to open on an ongoing basis, based on risk/benefit review.
If you have questions about
availability of clinical trials for cancer patients
, please contact
Lisa Gaynes
, Executive Director of Clinical Research Administration, or
Dr. Karyn Goodman
, Associate Director of Clinical Research.
|
|
Substance Abuse Clinical Services at Mount Sinai
The
Addiction Institute of Mount Sinai
(AIMS) provides inpatient and outpatient treatment services throughout New York City at Mount Sinai Beth Israel, Mount Sinai Morningside, Mount Sinai West, and The Mount Sinai Hospital.
Services include:
- Inpatient evaluation, group and individual counseling, detoxification, and rehabilitation
- Outpatient intensive programs, group and individual counseling, detoxification, and medication management
- Outpatient services specifically for children and adolescents
- A wide variety of medication-assisted opioid treatments
- The Respectful and Equitable Access to Comprehensive Healthcare (REACH) Program, for individuals who use drugs or alcohol, or are living with Hepatitis C
|
|
To make a referral call or email:
|
|
REACH Program
646-951-1693
|
|
Addiction Treatment Services
Mount Sinai Morningside
Mount Sinai West
212-523-6491
|
|
Addiction Treatment Services
Mount Sinai Beth Israel
212-256-2623
|
|
Mount Sinai Clinical Addition Research
212-824-9361
|
|
Refer Your Patients to Care Management
As a member of the clinically integrated network, you have access to
MSHP Care Management
, a team of nurses, social workers, and care coordinators on staff to help your patients overcome systemic barriers to healthcare and find appropriate care. We partner with you and your patients to address:
- Underutilization
- Emergency preparedness and crisis intervention
- Disease management
- Unmet needs such as housing, health literacy, financial security, community safety, linguistic and cultural alignment, substance misuse, interpersonal violence
For
questions or referrals
,
email us
or call 212-241-7228.
|
|
Purchase PPE through iRemedy
N95s, gowns, masks, and face shields are all available for purchase through iRemedy. To place an order, visit
iRemedy’s website
. Mount Sinai is not the seller or owner of the products being offered by iRemedy.
If you have any questions about the products or placing an order, please
contact
Marcus Allen
, Sales and Service Manager, iRemedy.
|
|
MSHP at the Forefront of Addressing Social Determinants of Health
Dr. Robert Fields, Chief Medical Officer of Mount Sinai Health Partners, made a guest appearance on Scripps National News to highlight Mount Sinai’s work with other health systems to address social needs as medical needs.
Watch the video
.
|
|
P: 877-234-6667
F: 646-537-1481
|
|
|
|
|
|
|
|
